This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Background The COVID-19 pandemic disrupted cardiovascular disease management in primary care in England. Results The percentage of patients aged ≥45 years who had bloodpressure screening recorded in the preceding 5 years decreased from 90% (March 2019) to 85% (March 2023).
Introduction COVID-19 may lead to long-term endothelial consequences including hypertension, stroke and myocardial infarction. A pilot study ‘COVID-19bloodpressure endothelium interaction study’, which found that patients with normal bloodpressure (BP) at the time of hospital admission with COVID-19 showed an 8.6
Cardiovascular diseases (CVDs) have been reported to occur in a significant number of patients diagnosed with coronavirus disease 2019 (COVID-19). We report our experience regarding the occurrence of symptomatic and asymptomatic CVDs in COVID-19 patients. In this cross-sectional study, 690 COVID-19 patients were included.
The effectiveness of mRNA-based vaccines in the recent COVID-19 pandemic has undoubtedly proven the benefits of an RNA-based approach. This is most evident in hypertension where several small interfering RNA–based drugs have proven to be effective in managing high bloodpressure in several clinical trials.
Participants aged ≥18 years with uncontrolled hypertension (5–7 day baseline mean ≥135 mm Hg systolic BP or ≥85 mm Hg diastolic BP) received personalized amlodipine dose titration using novel (1, 2, 3, 4, 6, 7, 8, 9 mg) and standard (5 and 10 mg) doses daily over 14 weeks.
Prolonged sitting also leads to a bending of major arteries in our legs, leading to a blood flow pattern known as turbulent flow, blood pooling, impaired circulation, and endothelial dysfunction. They also had measures of body weight and circumferences and bloodpressure assessed at these time points. kilograms (7.7
Hypertension, Ahead of Print. BACKGROUND:Pregnancy hypertension continues to cause maternal and perinatal morbidity. Within BUMP 2, chronic and gestational hypertension cohorts were analyzed separately. This article reports the trials’ integrated cost analyses.METHODS:Two cost analyses.
Background:Individuals with poorly controlled bloodpressure (BP) have a heightened risk of stroke and vascular cognitive impairment. Black Americans are disproportionately affected by hypertension and neurologic-target organ damage. Stroke, Volume 55, Issue Suppl_1 , Page AWP240-AWP240, February 1, 2024.
Between the COVID-19 pandemic and increasing amount of chronic diseases found in patients, the need for virtual healthcare has taken flight at an accelerated pace. We’ve technologically reached the point where we can easily monitor a range of helpful data points, including bloodpressure and glucose, weight, lung capacity and more.
IntroductionThe COVID-19 pandemic, starting in 2020, raised concerns about potential long-term health impacts, including its effects on cardiovascular health and related biomarkers. The study observed modest declines in mean glucose, cholesterol, HDL, and LDL levels post-pandemic, with stable bloodpressure.
6 [link] Insufficient sleep has been linked to a greater risk for several health conditions including obesity, diabetes, hypertension, and cognitive decline. 7 8 Sleep may have also played an underemphasized role in the COVID-19 pandemic. More than one-third of U.S.
Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)
Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)
exploring the cardiovascular phenotypes of 690 hospitalised COVID-19 patients in a tertiary centre in Iran. The authors found the prevalence of new-onset hypertension (as defined by a systolic bloodpressure [BP] 130mmHg and/or diastolic BP 80mmHg) was 10%.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content